$CNCE Headlines Concert Pharmaceuticals (CNCE)
Post# of 144476
Posted On: 04/21/2014 10:21:02 AM
$CNCE Headlines
Concert Pharmaceuticals (CNCE) Catches Eye: Stock Up 9.3% - Tale of the Tape 9:25 a.m. April 1, 2014 - Zacks.com
10-K: CONCERT PHARMACEUTICALS, INC. 6:51 a.m. March 31, 2014 - Edgar Online - (EDG = 10Q, 10K)
Concert Pharmaceuticals Quiet Period Expiration Could Be A Well-Orchestrated Long Opportunity For Investors 11:43 a.m. March 3, 2014 - Seeking Alpha
10-K: HERCULES TECHNOLOGY GROWTH CAPITAL INC 5:15 p.m. Feb. 27, 2014 - Edgar Online - (EDG = 10Q, 10K)
Auspex Is A Compelling Short Idea 11:14 a.m. Feb. 19, 2014 - Seeking Alpha
Concert Pharmaceuticals gains post-IPO 12:08 p.m. Feb. 13, 2014 - Seeking Alpha
IPO Preview: Concert Pharmaceuticals 2:00 a.m. Feb. 13, 2014 - Seeking Alpha
Concert Pharmaceuticals IPO Sounds Good 4:54 p.m. Feb. 12, 2014 - Seeking Alpha
Concert Pharmaceuticals, Inc. [CNCE] to Ring The NASDAQ Stock Market Opening Bell 10:01 a.m. April 11, 2014 - GlobeNewswire
Concert Pharmaceuticals Announces Filing of its Annual Report on Form 10-K 7:16 a.m. March 31, 2014 - BusinessWire - BZX
Concert Pharmaceuticals Reports Year End 2013 Financial Results 7:01 a.m. March 31, 2014 - BusinessWire - BZX
Concert Pharmaceuticals Announces CTP-499 Late Breaking Presentation at the National Kidney Foundation 2014 Spring Clinical Meeting 7:01 a.m. March 19, 2014 - BusinessWire - BZX
Company Profile for Concert Pharmaceuticals, Inc. 10:41 a.m. March 14, 2014 - BusinessWire - BZX
Concert Pharmaceuticals Appoints Wendell Wierenga to Board of Directors 7:00 a.m. March 14, 2014 - BusinessWire - BZX
Concert Pharmaceuticals Announces Exercise of Over-Allotment Option 12:31 p.m. March 3, 2014 - BusinessWire - BZX
Concert Pharmaceuticals to Present at the 26th Annual ROTH Conference on March 10, 2014 8:01 a.m. March 3, 2014 - BusinessWire - BZX
Hercules Technology Growth Capital Announces Fourth Quarter and Full-Year 2013 Financial Results and Announces Quarterly Dividend of $0.31 per Share 5:03 p.m. Feb. 27, 2014 - BusinessWire - BZX
Concert Pharmaceuticals Announces Closing of Initial Public Offering 12:30 p.m. Feb. 19, 2014 - BusinessWire - BZX
Concert Pharmaceuticals Announces Pricing of Initial Public Offering 9:01 a.m. Feb. 13, 2014 - BusinessWire - BZX
Concert Pharmaceuticals (CNCE) Catches Eye: Stock Up 9.3% - Tale of the Tape 9:25 a.m. April 1, 2014 - Zacks.com
10-K: CONCERT PHARMACEUTICALS, INC. 6:51 a.m. March 31, 2014 - Edgar Online - (EDG = 10Q, 10K)
Concert Pharmaceuticals Quiet Period Expiration Could Be A Well-Orchestrated Long Opportunity For Investors 11:43 a.m. March 3, 2014 - Seeking Alpha
10-K: HERCULES TECHNOLOGY GROWTH CAPITAL INC 5:15 p.m. Feb. 27, 2014 - Edgar Online - (EDG = 10Q, 10K)
Auspex Is A Compelling Short Idea 11:14 a.m. Feb. 19, 2014 - Seeking Alpha
Concert Pharmaceuticals gains post-IPO 12:08 p.m. Feb. 13, 2014 - Seeking Alpha
IPO Preview: Concert Pharmaceuticals 2:00 a.m. Feb. 13, 2014 - Seeking Alpha
Concert Pharmaceuticals IPO Sounds Good 4:54 p.m. Feb. 12, 2014 - Seeking Alpha
Concert Pharmaceuticals, Inc. [CNCE] to Ring The NASDAQ Stock Market Opening Bell 10:01 a.m. April 11, 2014 - GlobeNewswire
Concert Pharmaceuticals Announces Filing of its Annual Report on Form 10-K 7:16 a.m. March 31, 2014 - BusinessWire - BZX
Concert Pharmaceuticals Reports Year End 2013 Financial Results 7:01 a.m. March 31, 2014 - BusinessWire - BZX
Concert Pharmaceuticals Announces CTP-499 Late Breaking Presentation at the National Kidney Foundation 2014 Spring Clinical Meeting 7:01 a.m. March 19, 2014 - BusinessWire - BZX
Company Profile for Concert Pharmaceuticals, Inc. 10:41 a.m. March 14, 2014 - BusinessWire - BZX
Concert Pharmaceuticals Appoints Wendell Wierenga to Board of Directors 7:00 a.m. March 14, 2014 - BusinessWire - BZX
Concert Pharmaceuticals Announces Exercise of Over-Allotment Option 12:31 p.m. March 3, 2014 - BusinessWire - BZX
Concert Pharmaceuticals to Present at the 26th Annual ROTH Conference on March 10, 2014 8:01 a.m. March 3, 2014 - BusinessWire - BZX
Hercules Technology Growth Capital Announces Fourth Quarter and Full-Year 2013 Financial Results and Announces Quarterly Dividend of $0.31 per Share 5:03 p.m. Feb. 27, 2014 - BusinessWire - BZX
Concert Pharmaceuticals Announces Closing of Initial Public Offering 12:30 p.m. Feb. 19, 2014 - BusinessWire - BZX
Concert Pharmaceuticals Announces Pricing of Initial Public Offering 9:01 a.m. Feb. 13, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼